Intuitive Surgical (ISRG) Q3 Earnings Beat Expectations with Str
Intuitive Surgical (ISRG) reported Q3 earnings that surpassed expectations, with revenue of $3.05B, up 21.5% YoY, and EPS of $3.00. The company saw a 15% rise in procedures and placed 546 new da Vinci systems. ISRG's GF Value suggests it is undervalued by 31.1%, with a GF Score of 96/100. Insiders sold $93.4M in shares, while gurus show mixed activity.
How this was made
The 30-second read
Why it matters
The earnings beat is likely to trigger buying interest, though insider sales and a high valuation may temper enthusiasm.
Market read
Strong earnings from a large-cap healthcare device maker can lift the sector and attract short-term trader interest.
What to watch
High valuation multiples (P/E 50.2x) and moderate momentum may limit upside in the near term.
Background
Intuitive Surgical reported Q3 2026 results, beating consensus estimates on both EPS and revenue, and highlighted growth in da Vinci and Ion procedure volumes.
Ticker impact
Q3 earnings beat expectations with $3.00 EPS and $3.05B revenue, plus strong procedure volume growth.
likely upward pressure as investors price in the earnings beat and strong growth metrics
The company delivered better-than-expected earnings and revenue, and highlighted procedural volume increases, which typically drive short-term buying.
Market effects
Strengthens the medical devices sector outlook as a leading robotic surgery player shows robust growth.
Positive for U.S. healthcare equities, especially other surgical robotics firms.
Reinforces confidence in global demand for minimally invasive surgical technology.
Counterpoint
Insider selling of $93.4M could signal management concerns despite the earnings beat.
Key entities
- companyIntuitive Surgical Inc.
Leader in robotic-assisted minimally invasive surgery.

